Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company’s breast, lung and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. The firm sells its cancer diagnostic assays directly to oncologists and other physicians at hospitals and cancer centers. Geographically, it operates through United States, which is also the revenue generation region for the group.